BiotechTube
Home/Investors/Series C Investors

Series C Investors

Biotech Investor · 2 portfolio companies

Portfolio
2
Focus Areas
5
Top Stage
Phase 2

Investment Focus

Musculoskeletal DiseasesOsteoporosisOsteogenesis ImperfectaSpinal DisordersRare Genetic Diseases

Portfolio Companies

CompanyValuation
Angitia Biopharmaceuticals—
Arbor Biotechnologies—

Frequent Co-Investors

Series A Investors2 sharedSeries B Investors2 sharedSeries B+ Investors1 sharedSeries D Investors1 shared